StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2017, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 16 May 2016 11:45:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016 http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Mon, 16 May 2016 11:45:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016 http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Mon, 16 May 2016 11:45:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016 http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Mon, 16 May 2016 11:45:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016 http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Mon, 16 May 2016 11:45:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016 http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Mon, 16 May 2016 11:45:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016 http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Mon, 16 May 2016 11:45:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016 http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+to+Present+at+ChinaBio+Partnering+Forum+2016+in+Suzhou%2C+China+on+May+19%2C+2016/11635571.html Mon, 16 May 2016 11:45:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharma (XTLB) Completes Phase 2 Trial Design for hCDR1 in Lupus http://www.streetinsider.com/Corporate+News/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html for the full story. http://www.streetinsider.com/Corporate+News/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Mon, 21 Mar 2016 08:36:25 -0400 XTL XTLB XTLBY XTL Biopharma (XTLB) Completes Phase 2 Trial Design for hCDR1 in Lupus http://www.streetinsider.com/Corporate+News/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html for the full story. http://www.streetinsider.com/Corporate+News/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Mon, 21 Mar 2016 08:36:25 -0400 XTL XTLB XTLBY XTL Biopharma (XTLB) Completes Phase 2 Trial Design for hCDR1 in Lupus http://www.streetinsider.com/Corporate+News/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html for the full story. http://www.streetinsider.com/Corporate+News/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Mon, 21 Mar 2016 08:36:25 -0400 XTL XTLB XTLBY XTL Biopharma (XTLB) Completes Phase 2 Trial Design for hCDR1 in Lupus http://www.streetinsider.com/FDA/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html for the full story. http://www.streetinsider.com/FDA/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Mon, 21 Mar 2016 08:36:25 -0400 XTL XTLB XTLBY XTL Biopharma (XTLB) Completes Phase 2 Trial Design for hCDR1 in Lupus http://www.streetinsider.com/FDA/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html for the full story. http://www.streetinsider.com/FDA/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Mon, 21 Mar 2016 08:36:25 -0400 XTL XTLB XTLBY XTL Biopharma (XTLB) Completes Phase 2 Trial Design for hCDR1 in Lupus http://www.streetinsider.com/FDA/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Visit StreetInsider.com at http://www.streetinsider.com/FDA/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html for the full story. http://www.streetinsider.com/FDA/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Mon, 21 Mar 2016 08:36:25 -0400 XTL XTLB XTLBY XTL Biopharma (XTLB) Completes Phase 2 Trial Design for hCDR1 in Lupus http://www.streetinsider.com/Management+Comments/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html for the full story. http://www.streetinsider.com/Management+Comments/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Mon, 21 Mar 2016 08:36:25 -0400 XTL XTLB XTLBY XTL Biopharma (XTLB) Completes Phase 2 Trial Design for hCDR1 in Lupus http://www.streetinsider.com/Management+Comments/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html for the full story. http://www.streetinsider.com/Management+Comments/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Mon, 21 Mar 2016 08:36:25 -0400 XTL XTLB XTLBY XTL Biopharma (XTLB) Completes Phase 2 Trial Design for hCDR1 in Lupus http://www.streetinsider.com/Management+Comments/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html for the full story. http://www.streetinsider.com/Management+Comments/XTL+Biopharma+%28XTLB%29+Completes+Phase+2+Trial+Design+for+hCDR1+in+Lupus/11435442.html Mon, 21 Mar 2016 08:36:25 -0400 XTL XTLB XTLBY XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of Lupus http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Mon, 21 Mar 2016 08:30:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of Lupus http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Mon, 21 Mar 2016 08:30:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of Lupus http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Mon, 21 Mar 2016 08:30:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of Lupus http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Mon, 21 Mar 2016 08:30:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of Lupus http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Mon, 21 Mar 2016 08:30:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of Lupus http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Mon, 21 Mar 2016 08:30:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of Lupus http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html for the full story. http://www.streetinsider.com/Press+Releases/XTL+Biopharmaceuticals+Completes+Phase+2+Trial+Design+for+Lead+Compound+hCDR1+in+the+Treatment+of+Lupus/11435415.html Mon, 21 Mar 2016 08:30:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY Lupus Thought Leader Daphna Paran, MD, Named Medical Director of XTL Biopharmaceuticals http://www.streetinsider.com/Press+Releases/Lupus+Thought+Leader+Daphna+Paran%2C+MD%2C+Named+Medical+Director+of+XTL+Biopharmaceuticals/11404017.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Lupus+Thought+Leader+Daphna+Paran%2C+MD%2C+Named+Medical+Director+of+XTL+Biopharmaceuticals/11404017.html for the full story. http://www.streetinsider.com/Press+Releases/Lupus+Thought+Leader+Daphna+Paran%2C+MD%2C+Named+Medical+Director+of+XTL+Biopharmaceuticals/11404017.html Wed, 09 Mar 2016 08:29:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY Lupus Thought Leader Daphna Paran, MD, Named Medical Director of XTL Biopharmaceuticals http://www.streetinsider.com/Press+Releases/Lupus+Thought+Leader+Daphna+Paran%2C+MD%2C+Named+Medical+Director+of+XTL+Biopharmaceuticals/11404017.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Lupus+Thought+Leader+Daphna+Paran%2C+MD%2C+Named+Medical+Director+of+XTL+Biopharmaceuticals/11404017.html for the full story. http://www.streetinsider.com/Press+Releases/Lupus+Thought+Leader+Daphna+Paran%2C+MD%2C+Named+Medical+Director+of+XTL+Biopharmaceuticals/11404017.html Wed, 09 Mar 2016 08:29:00 -0400 A.05968641 A.06822034 A.29302616 XTL XTL XTLB XTLBY